GE warns over anesthesia devices; Medtronic, RTI unite on spinal implants;

@FierceMedDev: ICYMI yesterday: FierceMedicalDevices' 2013 Fierce 15. Feature | Follow @FierceMedDev

> GE Healthcare ($GE) is warning customers that some of its anesthesia delivery systems can malfunction, leading to higher-than-expected dosing. News

> MDxHealth plans to expand its PredictMDx brain tumor test in the U.S. now that the diagnostic has been included in the guidelines of the National Comprehensive Cancer Network. More

> RTI ($RTIX) has signed a deal with Medtronic ($MDT) to distribute allograft implants for use in spinal surgeries. Announcement

> Australia's Osprey Medical is raising about $13.4 million through a private placement to support its FDA-cleared interventional cardiology device. Release

> Device incubator Inceptus Medical has raised $4.7 million to launch its first company, the cardiovascular-focused Inari Medical. Item

Biotech News

@FierceBiotech: ICYMI yesterday: The top Phase III R&D setbacks of 2013. Feature | Follow @FierceBiotech

@JohnCFierce: Third Rock startup banks $20M to fuel next leg of CNS drug development journey. News | Follow @JohnCFierce

@DamianFierce: St. Jude boosts profits as job cuts, M&A pay off. Article | Follow @DamianFierce

@EmilyMFierce: Georgetown University Medical Center researchers find a vegetable-based compound that protects against side effects of radiation therapy. Article from FierceBiotech Research | Follow @EmilyMFierce

> Is Eli Lilly about to start cutting its blockbuster R&D budget? More

> MedImmune leads $12.5M round for new drug aimed at big chemo market. Article

> Sanofi, Regeneron take the lead in blockbuster PhIII race of PCSK9 drugs. Story

Pharma News

@FiercePharma: Top news online yesterday: J&J hikes earnings forecast on pharma's superhero sales flight. Story | Follow @FiercePharma

@EricPFierce: MHRA says it also took action against Wockhardt contractor Nestor in U.K. as part of recent action. Article from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Look out, Vivus--Eisai to double Belviq sales force by December 2013. Release | Follow @CarlyHFierce

> Sanofi invests in Fabrazyme production as sales soar. Report

> Teva halts Israeli layoff plans amid pressure from labor, government. Article

> Telegraph: GlaxoSmithKline's ex-China chief barred from leaving country. Story

Biomarkers News

> Biomarker differentiates ADHD subtypes, offers clues for treatment. Article

> Amgen taps KineMed for Alzheimer's biomarkers. Report

> Skin may conceal a viable Parkinson's biomarker. Story

Drug Delivery News

@MichaelGFierce: AstraZeneca teams with Taris to research bladder cancer delivery device. Story | Follow @MichaelGFierce

> Mini-pancreas grown from stem cells has implications for future insulin delivery. More

> Cell membrane models 'written' on graphene provide drug-delivery model. Item

> Study: Synthetic RNA conjugates target, silence bacteria's genetic material. Article

> Nanoparticle hydrogel heats up to release drugs in active cartilage. Story

Diagnostics News

@MarkHFierce: Smith & Nephew will handle U.S. distribution of a women's care diagnostic device developed by Femasys. Story | Follow @MarkHFierce

> Applied Proteomics to develop pancreatic and colon cancer Dx with German research institute. More

> Quest preemptively sues Myriad to ensure new BRCA test avoids patent violation. Report

> CardioDx's proposed $86.2M IPO will aid marketing and insurance coverage efforts. Story

> New blood test screens for irritable bowel syndrome. Article

> Mount Sinai's Icahn School of Medicine jumps into Dx, drug development. Item

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.